In summary, human genetic studies and murine models demonstrated that CHIP mutations were associated with obesity and that targeting CHIP-mutant cells with drugs such as metformin, nifedipine, MCC950, or anakinra may be a reasonable approach to treat CH. The gene discussed is STUB1; the disease is Obesity.